BridgeMD
New treatment option for Nicotine Dependence
Official title Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients
ClinicalTrials.gov ID: NCT07466875
What this study is testing
What is Nicotine Replacement Therapy (Nicotine patch plus NRT gum or lozenge)?
Nicotine Replacement Therapy (Nicotine patch plus NRT gum or lozenge) is an investigational medicine, given as an once-daily, being studied as a potential treatment for nicotine dependence.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to evaluate the feasibility and preliminary effectiveness of auricular acupressure (ear seeds) combined with nicotine replacement therapy (NRT) in psychiatric inpatients (both male and female, aged 18-65) who are forced to abstain from smoking due to the smoke-free environment of the inpatient ward. The main questions it aims to answer are: Does auricular acupressure significantly reduce the severity of nicotine withdrawal symptoms compared to standard care?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Psychiatric inpatients aged 18 to 65 years.
- Diagnosed with a mental disorder according to ICD-10-CM criteria.
- History of daily smoking within the past six months (Fagerström Test for Nicotine Dependence [FTND] score ≥ 2).
- Experiencing nicotine withdrawal symptoms due to mandatory smoking cessation upon admission (Minnesota Tobacco Withdrawal Scale [MNWS] baseline score...
- Agree to and comply with the standard-of-care Nicotine Replacement Therapy (NRT) provided by the hospital.
You likely can't join if
- Presence of severe skin infection, open wounds, or lesions on the auricle (outer ear).
- Severe coagulation disorders or currently taking high-dose anticoagulants (due to potential risk of bleeding or irritation).
- Pregnant or breastfeeding women.
- Significant language barriers or cognitive impairment that prevents completion of assessment scales or adherence to study protocols.
- History of receiving auricular therapy for smoking cessation within the past three months.
See the full eligibility criteria
- Psychiatric inpatients aged 18 to 65 years.
- Diagnosed with a mental disorder according to ICD-10-CM criteria.
- History of daily smoking within the past six months (Fagerström Test for Nicotine Dependence [FTND] score ≥ 2).
- Experiencing nicotine withdrawal symptoms due to mandatory smoking cessation upon admission (Minnesota Tobacco Withdrawal Scale [MNWS] baseline score ≥ 5).
- Agree to and comply with the standard-of-care Nicotine Replacement Therapy (NRT) provided by the hospital.
- Capable of understanding the study procedures and providing written informed consent
- Presence of severe skin infection, open wounds, or lesions on the auricle (outer ear).
- Severe coagulation disorders or currently taking high-dose anticoagulants (due to potential risk of bleeding or irritation).
- Pregnant or breastfeeding women.
- Significant language barriers or cognitive impairment that prevents completion of assessment scales or adherence to study protocols.
- History of receiving auricular therapy for smoking cessation within the past three months.
The study team makes the final eligibility decision.
Where it's taking place
- Nantou City, Taiwan
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nantou City, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.